Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Targeting Genomic Heterogeneity of Adult Acute Lymphoblastic Leukemia

Annette Fasan, PhD, Melanie Zenger, Madlen Ulke, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD

Blood (2014) 124 (21): 2407.

https://doi.org/10.1182/blood.V124.21.2407.2407

Published: 2014

Journal Articles

Investigation Of Seven Genes Commonly Deleted In 271 Adult ALL Patients: Association With Cytogenetics and Clinical Features

Annette Fasan, PhD, Claudia Haferlach, MD, Madlen Ulke, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 2611.

https://doi.org/10.1182/blood.V122.21.2611.2611

Published: 2013

Journal Articles

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

Susanne Schnittger, PhD, Christiane Eder, PhD, Tamara Alpermann, Frank Dicker, PhD, Madlen Ulke, Alexander Kohlmann, PhD, Sabrina Kuznia, MSc, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2013) 122 (21): 2542.

https://doi.org/10.1182/blood.V122.21.2542.2542

Published: 2013

Journal Articles

IKZF1 deletions Are Detected In 40.3% Of 270 Adult B-Precursor-ALL and Are Independently Associated With BCR-ABL1 Positivity and Inferior Outcome

Annette Fasan, PhD, Claudia Haferlach, MD, Madlen Ulke, Wolfgang Kern, MD, Torsten Haferlach, MD, Susanne Schnittger, PhD

Blood (2013) 122 (21): 1372.

https://doi.org/10.1182/blood.V122.21.1372.1372

Published: 2013

Journal Articles

Development and validation of a real-time quantification assay to detect and monitor BRAF V600E mutations in hairy cell leukemia

Susanne Schnittger, Ulrike Bacher, Torsten Haferlach, Nicole Wendland, Madlen Ulke, Frank Dicker, Vera Grossmann, Claudia Haferlach, Wolfgang Kern

Blood (2012) 119 (13): 3151–3154.

https://doi.org/10.1182/blood-2011-10-383323

Published: 2012

Journal Articles

Development and Validation of a Real Time Quantification Assay to Detect and Monitor BRAF V600E-Mutations in Hairy Cell Leukemia,

Susanne Schnittger, PhD, Torsten Haferlach, MD, Nicole Wendland, Madlen Ulke, Vera Grossmann, MSc, Claudia Haferlach, MD, Wolfgang Kern, MD

Blood (2011) 118 (21): 3674.

https://doi.org/10.1182/blood.V118.21.3674.3674

Published: 2011

Journal Articles

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

Susanne Schnittger, Claudia Haferlach, Madlen Ulke, Tamara Alpermann, Wolfgang Kern, Torsten Haferlach

Blood (2010) 116 (25): 5486–5496.

https://doi.org/10.1182/blood-2010-02-267955

Published: 2010

Journal Articles

CBL Mutations Are Correlated with CMML, Frequently Associated with RUNX1 but Mutually Exclusive of JAK2V617F Mutations.

Susanne Schnittger, PhD, Andreas Reiter, MD, Madlen Ulke, Alexandra Spiel, Frank Dicker, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2009) 114 (22): 962.

https://doi.org/10.1182/blood.V114.22.962.962

Published: 2009

Journal Articles

IDH1 Mutations Are Detected in 9.3% of All AML and Are Strongly Associated with Intermediate Risk Karyotype and Unfavourable Prognosis: a Study of 999 Patients

Susanne Schnittger, PhD, Claudia Haferlach, MD, Madlen Ulke, Leyla Kaya, Tamara Weiss, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2009) 114 (22): LBA-3.

https://doi.org/10.1182/blood.V114.22.LBA-3.LBA-3

Published: 2009

Journal Articles

Analysis of Genetic Variants and Expression Levels of Human Organic Cation Transporter 1 (HOCT1) and Genetic Variants in MDR1 in CML: Weak Associations Were Detected but a Major Role in Clinical Response to Imatinib Resistance Is Unlikely

Susanne Schnittger, PhD, Sonja Rauhut, Claudia Tschulik, Madlen Ulke, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2008) 112 (11): 3203.

https://doi.org/10.1182/blood.V112.11.3203.3203

Published: 2008

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Targeting Genomic Heterogeneity of Adult Acute Lymphoblastic Leukemia

Investigation Of Seven Genes Commonly Deleted In 271 Adult ALL Patients: Association With Cytogenetics and Clinical Features

WT1 Mutations Are Secondary Events In AML and Show Varying Frequencies Within Genetic Subgroups and Different Impact On Prognosis

IKZF1 deletions Are Detected In 40.3% Of 270 Adult B-Precursor-ALL and Are Independently Associated With BCR-ABL1 Positivity and Inferior Outcome

Development and validation of a real-time quantification assay to detect and monitor BRAF V600E mutations in hairy cell leukemia

Development and Validation of a Real Time Quantification Assay to Detect and Monitor BRAF V600E-Mutations in Hairy Cell Leukemia,

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

CBL Mutations Are Correlated with CMML, Frequently Associated with RUNX1 but Mutually Exclusive of JAK2V617F Mutations.

IDH1 Mutations Are Detected in 9.3% of All AML and Are Strongly Associated with Intermediate Risk Karyotype and Unfavourable Prognosis: a Study of 999 Patients

Analysis of Genetic Variants and Expression Levels of Human Organic Cation Transporter 1 (HOCT1) and Genetic Variants in MDR1 in CML: Weak Associations Were Detected but a Major Role in Clinical Response to Imatinib Resistance Is Unlikely

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only